These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29710478)

  • 21. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T; Staels B; Kuipers F
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesoid X receptor: from medicinal chemistry to clinical applications.
    Fiorucci S; Mencarelli A; Distrutti E; Zampella A
    Future Med Chem; 2012 May; 4(7):877-91. PubMed ID: 22571613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S; Rizzo G; Donini A; Distrutti E; Santucci L
    Trends Mol Med; 2007 Jul; 13(7):298-309. PubMed ID: 17588816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.
    Staudinger JL; Lichti K
    Mol Pharm; 2008; 5(1):17-34. PubMed ID: 18159925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE).
    Downing LE; Edgar D; Ellison PA; Ricketts ML
    Cell Biochem Funct; 2017 Jan; 35(1):12-32. PubMed ID: 28083965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes.
    Wang H; LeCluyse EL
    Clin Pharmacokinet; 2003; 42(15):1331-57. PubMed ID: 14674787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors.
    Trottier J; Milkiewicz P; Kaeding J; Verreault M; Barbier O
    Mol Pharm; 2006; 3(3):212-22. PubMed ID: 16749854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sweet dreams for LXR.
    Lazar MA; Willson TM
    Cell Metab; 2007 Mar; 5(3):159-61. PubMed ID: 17339022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis.
    Goodwin B; Kliewer SA
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G926-31. PubMed ID: 12016116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bile acids in regulation of inflammation and immunity: friend or foe?
    Zhu C; Fuchs CD; Halilbasic E; Trauner M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):25-31. PubMed ID: 27586800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear receptor regulation of lipid metabolism: potential therapeutics for dyslipidemia, diabetes, and chronic heart and liver diseases.
    Chiang JY
    Curr Opin Investig Drugs; 2005 Oct; 6(10):994-1001. PubMed ID: 16259220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of FXR in disorders of bile acid homeostasis.
    Eloranta JJ; Kullak-Ublick GA
    Physiology (Bethesda); 2008 Oct; 23():286-95. PubMed ID: 18927204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ubiquitination of nuclear receptors.
    El Hokayem J; Amadei C; Obeid JP; Nawaz Z
    Clin Sci (Lond); 2017 May; 131(10):917-934. PubMed ID: 28473472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
    Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?
    Rudraiah S; Zhang X; Wang L
    Annu Rev Pharmacol Toxicol; 2016; 56():605-626. PubMed ID: 26738480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
    Fiorucci S; Mencarelli A; Palladino G; Cipriani S
    Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine functions of bile acids.
    Houten SM; Watanabe M; Auwerx J
    EMBO J; 2006 Apr; 25(7):1419-25. PubMed ID: 16541101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model.
    Kunne C; Acco A; Duijst S; de Waart DR; Paulusma CC; Gaemers I; Oude Elferink RP
    Biochim Biophys Acta; 2014 May; 1842(5):739-46. PubMed ID: 24548803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation.
    Treuter E; Venteclef N
    Biochim Biophys Acta; 2011 Aug; 1812(8):909-18. PubMed ID: 21172431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.